Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/8948Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Thaker, K M | - |
| dc.contributor.author | Joshi, H S | - |
| dc.date.accessioned | 2010-05-14T11:20:27Z | - |
| dc.date.available | 2010-05-14T11:20:27Z | - |
| dc.date.issued | 2005-02 | - |
| dc.identifier.issn | 0975-0983(Online); 0376-4699(Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/8948 | - |
| dc.description | 410-412 | en_US |
| dc.description.abstract | The condensation of 2-hydrazinocarbonyl-3,5-dichlorobenzo[b]thiophene 1 with different arylisothiocyanate yields N1-(3,5-dichlorobenzo[b]thiophen-2-yl)-N4-substituted arylthiosemicarbazides 2a-j. Reaction of 2a-j with conc. H2SO4 affords the corresponding 2-(3’,5’-dichlorobenzo[b]thiophen-2’-yl)-5-arylamino-1,3,4-thiadiazoles 3a-j. The pharmacological evaluations have been performed for their antimicrobial and antitubercular activities. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.relation.ispartofseries | Int.Cl.7 C 07 D 285/12 | en_US |
| dc.source | IJC-B Vol.44B(02) [February 2005] | en_US |
| dc.title | Synthesis and pharmacological evaluation of 2-(3’,5’-dichlorobenzo[b]thiophen-2’-yl)-5-arylamino-1,3,4-thiadiazoles | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.44B(02) [February 2005] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 44B(2) 410-412.pdf | 55.93 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.